Total Payments
$2,327
2024 Payments
$1,297
Companies
19
Transactions
104
Medicare Patients
18,527
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$2,297 (98.7%)
Education$30.00 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,297 | 103 | 98.7% |
| Education | $30.00 | 1 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $684.81 | 28 | $0 (2024) |
| Lilly USA, LLC | $227.51 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $225.84 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $190.68 | 5 | $0 (2024) |
| Amgen Inc. | $178.60 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $158.34 | 8 | $0 (2024) |
| LEO Pharma Inc. | $141.97 | 6 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $140.75 | 7 | $0 (2024) |
| GENZYME CORPORATION | $115.81 | 4 | $0 (2024) |
| PFIZER INC. | $68.25 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,297 | 58 | ABBVIE INC. ($383.21) |
| 2023 | $244.04 | 11 | Amgen Inc. ($53.49) |
| 2022 | $290.52 | 14 | ABBVIE INC. ($108.36) |
| 2021 | $228.87 | 12 | Lilly USA, LLC ($96.46) |
| 2020 | $173.46 | 4 | AbbVie Inc. ($105.79) |
| 2019 | $13.50 | 1 | Genentech USA, Inc. ($13.50) |
| 2018 | $69.29 | 3 | DUSA Pharmaceuticals, Inc. ($39.29) |
| 2017 | $10.40 | 1 | PFIZER INC. ($10.40) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $35.55 | General |
| 12/10/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.58 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Dermatology | ||||||
| 10/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $23.21 | General |
| 09/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $36.21 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.21 | General |
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Dermatology | ||||||
| 09/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Dermatology | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 4,832 | 11,055 | $1.1M | $339,246 |
| 2022 | 17 | 4,604 | 10,254 | $1.1M | $342,702 |
| 2021 | 16 | 4,538 | 10,374 | $1.1M | $342,078 |
| 2020 | 21 | 4,553 | 9,864 | $1.1M | $340,677 |
Total Patients
18,527
Total Services
41,547
Medicare Billing
$1.4M
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,407 | 2,023 | $380,000 | $118,528 | 31.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,018 | 1,358 | $216,112 | $55,684 | 25.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 503 | 586 | $125,580 | $41,272 | 32.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 214 | 294 | $103,068 | $35,831 | 34.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 858 | 5,794 | $85,867 | $28,772 | 33.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 137 | 172 | $40,520 | $13,190 | 32.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 186 | 186 | $43,104 | $13,132 | 30.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 210 | 230 | $26,501 | $9,056 | 34.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 129 | 227 | $25,444 | $9,047 | 35.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 38 | 42 | $15,558 | $5,085 | 32.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 31 | 34 | $10,444 | $3,227 | 30.9% |
| 69100 | Biopsy of ear | Office | 2023 | 46 | 51 | $10,915 | $2,779 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 28 | $7,462 | $2,142 | 28.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 30 | 30 | $4,715 | $1,501 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 1,250 | 1,852 | $348,037 | $110,402 | 31.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 563 | 716 | $153,439 | $50,216 | 32.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 888 | 1,262 | $200,835 | $48,188 | 24.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 192 | 251 | $87,993 | $31,594 | 35.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 725 | 4,916 | $72,855 | $24,555 | 33.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 172 | 215 | $50,650 | $17,457 | 34.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 189 | 374 | $41,922 | $15,104 | 36.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 194 | 194 | $44,958 | $13,599 | 30.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 181 | 203 | $23,390 | $7,863 | 33.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 45 | 50 | $18,521 | $6,374 | 34.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 37 | 40 | $12,287 | $4,152 | 33.8% |
About Dr. Bruce Fuller, M.D
Dr. Bruce Fuller, M.D is a Dermatology healthcare provider based in Reno, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588861397.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Fuller, M.D has received a total of $2,327 in payments from pharmaceutical and medical device companies, with $1,297 received in 2024. These payments were reported across 104 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,297).
As a Medicare-enrolled provider, Fuller has provided services to 18,527 Medicare beneficiaries, totaling 41,547 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Reno, NV
- Active Since 06/27/2007
- Last Updated 01/21/2026
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588861397
Products in Payments
- SKYRIZI (Biological) $450.55
- DUPIXENT (Biological) $240.47
- TALTZ (Drug) $204.30
- Sotyktu (Drug) $190.68
- Otezla (Drug) $164.95
- ADBRY (Biological) $111.97
- Winlevi (Drug) $91.67
- LIBTAYO (Biological) $82.38
- RINVOQ (Biological) $77.26
- COSENTYX (Drug) $68.68
- EUCRISA (Drug) $68.25
- HUMIRA (Biological) $51.21
- Absorica LD (Drug) $34.64
- AMZEEQ (Drug) $32.32
- COSENTYX (Biological) $24.70
- XOLAIR (Biological) $21.70
- BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 (Device) $21.02
- AKLIEF (Drug) $18.95
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $18.27
- GRAFIX (Medical Supply) $14.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Reno
Laura Ostezan, M.d, M.D
Dermatology — Payments: $27,692
Dermatology $27,692
Laura Biehle, Pa-C, PA-C
Dermatology — Payments: $25,736
Dermatology $25,736
Dr. William Mortensen, M.d, M.D
Dermatology — Payments: $12,827
Dermatology $12,827
Mrs. Diane Smith, Aprn, APRN
Dermatology — Payments: $11,999
Dermatology $11,999
Mrs. Cindy Lamerson, Md, MD
Dermatology — Payments: $8,873
Dermatology $8,873
Dr. Gretchen Korver, M.d, M.D
Dermatology — Payments: $8,444
Dermatology $8,444